147 related articles for article (PubMed ID: 3572549)
1. Imaging of metastases of thyroid carcinoma with fluorine-18 fluorodeoxyglucose.
Joensuu H; Ahonen A
J Nucl Med; 1987 May; 28(5):910-4. PubMed ID: 3572549
[TBL] [Abstract][Full Text] [Related]
2. Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer.
Feine U; Lietzenmayer R; Hanke JP; Held J; Wöhrle H; Müller-Schauenburg W
J Nucl Med; 1996 Sep; 37(9):1468-72. PubMed ID: 8790195
[TBL] [Abstract][Full Text] [Related]
3. [18FDG whole-body PET in differentiated thyroid carcinoma. Flipflop in uptake patterns of 18FDG and 131I].
Feine U; Lietzenmayer R; Hanke JP; Wöhrle H; Müller-Schauenburg W
Nuklearmedizin; 1995 Aug; 34(4):127-34. PubMed ID: 7675641
[TBL] [Abstract][Full Text] [Related]
4. Whole-body scintigraphy with 99Tcm-MIBI, 18F-FDG and 131I in patients with metastatic thyroid carcinoma.
Fridrich L; Messa C; Landoni C; Lucignani G; Moncayo R; Kendler D; Riccabona G; Fazio F
Nucl Med Commun; 1997 Jan; 18(1):3-9. PubMed ID: 9061694
[TBL] [Abstract][Full Text] [Related]
5. Cervical lymph node metastasis of thyroid papillary carcinoma imaged with fluorine-18-FDG, technetium-99m-pertechnetate and iodine-131-sodium iodide.
Scott GC; Meier DA; Dickinson CZ
J Nucl Med; 1995 Oct; 36(10):1843-5. PubMed ID: 7562053
[TBL] [Abstract][Full Text] [Related]
6. 18F-fluorodeoxyglucose imaging in preoperative diagnosis of thyroid malignancy.
Joensuu H; Ahonen A; Klemi PJ
Eur J Nucl Med; 1988; 13(10):502-6. PubMed ID: 3371370
[TBL] [Abstract][Full Text] [Related]
7. Increased accumulation of 2-deoxy-2-[18F]Fluoro-D-glucose in liver metastases from colon carcinoma.
Yonekura Y; Benua RS; Brill AB; Som P; Yeh SD; Kemeny NE; Fowler JS; MacGregor RR; Stamm R; Christman DR; Wolf AP
J Nucl Med; 1982 Dec; 23(12):1133-7. PubMed ID: 6982967
[TBL] [Abstract][Full Text] [Related]
8. Uptake of 18-fluoro-2-deoxy-D-glucose by thyroid cancer: implications for diagnosis and therapy.
Sisson JC; Ackermann RJ; Meyer MA; Wahl RL
J Clin Endocrinol Metab; 1993 Oct; 77(4):1090-4. PubMed ID: 8408458
[TBL] [Abstract][Full Text] [Related]
9. Feasibility and benefit of fluorine 18-fluoro-2-deoxyglucose-guided surgery in the management of radioiodine-negative differentiated thyroid carcinoma metastases.
Kraeber-Bodéré F; Cariou B; Curtet C; Bridji B; Rousseau C; Dravet F; Charbonnel B; Carnaille B; Le Néel JC; Mirallié E
Surgery; 2005 Dec; 138(6):1176-82; discussion 1182. PubMed ID: 16360406
[TBL] [Abstract][Full Text] [Related]
10. [Value of scintigraphic explorations by radiomarkers others than iodine radioisotope in differentiated thyroid cancer].
Sassolas G; Houzard C; Sigartau C; Borson-Chazot F
Ann Endocrinol (Paris); 1997; 58(1):55-63. PubMed ID: 9207967
[TBL] [Abstract][Full Text] [Related]
11. Early changes in fluorine-18-FDG uptake during radiotherapy.
Hautzel H; Müller-Gärtner HW
J Nucl Med; 1997 Sep; 38(9):1384-6. PubMed ID: 9293793
[TBL] [Abstract][Full Text] [Related]
12. F-18 FDG uptake by recurrent Hürthle cell carcinoma of the thyroid using high-energy planar scintigraphy.
Blount CL; Dworkin HJ
Clin Nucl Med; 1996 Nov; 21(11):831-3. PubMed ID: 8922841
[TBL] [Abstract][Full Text] [Related]
13. Comparison of fluorine-18-2-fluorodeoxyglucose and gallium-67 citrate imaging for detection of lymphoma.
Paul R
J Nucl Med; 1987 Mar; 28(3):288-92. PubMed ID: 3469332
[TBL] [Abstract][Full Text] [Related]
14. Scintigraphy with [18F]2-fluoro-2-deoxy-D-glucose of cancer patients.
Paul R; Roeda D; Johansson R; Ahonen A; Haaparanta M; Solin O; Sipilä H
Int J Rad Appl Instrum B; 1986; 13(1):7-12. PubMed ID: 3771240
[TBL] [Abstract][Full Text] [Related]
15. Positron emission tomography of thyroid masses.
Adler LP; Bloom AD
Thyroid; 1993; 3(3):195-200. PubMed ID: 8257858
[TBL] [Abstract][Full Text] [Related]
16. [Metastatic differentiated thyroid cancer. Diagnostic accuracy of thyroglobulin-RIA in comparison with 131I-whole body scintigraphy].
Reiners C; Reimann J; Schäffer R; Baum K; Becker W; Eilles C; Gerhards W; Schick F; Spiegel W; Wiedemann W
Rofo; 1984 Sep; 141(3):306-13. PubMed ID: 6435198
[TBL] [Abstract][Full Text] [Related]
17. Resistance of [18f]-fluorodeoxyglucose-avid metastatic thyroid cancer lesions to treatment with high-dose radioactive iodine.
Wang W; Larson SM; Tuttle RM; Kalaigian H; Kolbert K; Sonenberg M; Robbins RJ
Thyroid; 2001 Dec; 11(12):1169-75. PubMed ID: 12186505
[TBL] [Abstract][Full Text] [Related]
18. Comparison of whole-body 18F-FDG SPECT and posttherapeutic 131I scintigraphy in the detection of metastatic thyroid cancer.
Wang H; Fu HL; Li JN; Zhou RJ; Hui Gu Z; Wu JC; Huang G
Clin Imaging; 2008; 32(1):32-7. PubMed ID: 18164392
[TBL] [Abstract][Full Text] [Related]
19. Tc-99m-pertechnetate scanning in metastatic thyroid carcinoma: a case report.
Lamberigts G; De Roo M; Devos P; Burie D
Clin Nucl Med; 1981 Apr; 6(4):172-4. PubMed ID: 7214773
[TBL] [Abstract][Full Text] [Related]
20. Determination of malignancy of thyroid nodules with positron emission tomography.
Bloom AD; Adler LP; Shuck JM
Surgery; 1993 Oct; 114(4):728-34; discussion 734-5. PubMed ID: 8211687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
